￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
NCCN recommends Revumenib-Revuforj for R/R NPM1+ acute myeloid leukemia

2026-02-01 22:25:32

Check Details
What is the listing price of Selegiline?

2026-02-01 22:25:32

Check Details
How long does it take to see obvious effects of Canafenib/Encofenib (Betavit)?

2026-02-01 22:25:32

Check Details
How long will it take for long-term use of imatinib (Gleevec) to develop resistance and countermeasures?

2026-02-01 22:25:32

Check Details
Analysis of formal purchasing channels and patient purchasing guide for ruxolitinib cream (Opzelura)

2026-02-01 22:25:32

Check Details
Analysis of common side effects and treatment methods of Epclusa

2026-02-01 22:25:32

Check Details
Analysis of the diseases and indications that Sunitinib (Sutent) mainly treats

2026-02-01 22:25:32

Check Details
Duration of adverse reactions and safe handling methods of Tazetostat (Taveco)

2026-02-01 22:25:32

Check Details
Is there a patient assistance program for ceritinib/ceritinib and how to apply?

2026-02-01 22:25:32

Check Details
Evaluation of the tumor treatment effect of Bestivan (Viliru) and real feedback from patients

2026-02-01 22:25:32

Check Details
Precautions and safe medication guidelines while taking Dabrafenib (Tefilla)

2026-02-01 22:25:32

Check Details
Introduction to Axitinib manufacturers and their global market supply capabilities

2026-02-01 22:25:32

Check Details
Category
相关知识